JAK2/JAK1 Inhibitors (IC50, Ki)
Structure ▲ ▼ | Compound Name ▲ ▼ | Standard Type ▲ ▼ | Standard Values (in nM) ▲ ▼ |
Tofacitinib | IC50 | 170.0 [1] | |
Filgotinib | IC50 | 1045.0 [1], 3364.0 [2] | |
N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide | IC50 | 163.0 [1], 271.0 [2] | |
Jak-IN-1 | IC50 | 290.0 [1], 291.0 [2] | |
Ruxolitinib | IC50 | 31.0 [1] | |
[2-[6-(2-Ethyl-5-fluoro-4-hydroxyphenyl)-1H-indazol-3-yl]-3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl]-(5-piperidin-1-ylpyrazin-2-yl)methanone | IC50 | 2100.0 [1] | |
N-[(2R)-1-(3-Cyanoazetidin-1-yl)-1-oxopropan-2-yl]-2-cyclopropyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide | IC50 | 2540.0 [1] | |
2-Cyclopropyl-N-[(2s)-3-Hydroxy-3-Methylbutan-2-Yl]-5h-Pyrrolo[2,3-B]pyrazine-7-Carboxamide | IC50 | 13200.0 [1] | |
N-[(1R)-2-(3-Cyanoazetidin-1-yl)-1-cyclopropyl-2-oxoethyl]-2-cyclopropyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide | IC50 | 141.0 [1] | |
N-[(1R)-2-[(3S)-3-Cyanopyrrolidin-1-yl]-1-cyclopropyl-2-oxoethyl]-2-cyclopropyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide | IC50 | 102.0 [1] |
References
This online tool may be cited as follows
MLA | "Quest Database™ JAK2/JAK1 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 21 Nov. 2024, https://www.aatbio.com/data-sets/jak2-jak1-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2024, November 21). Quest Database™ JAK2/JAK1 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/jak2-jak1-inhibitors-ic50-ki. | |
BibTeX | EndNote | RefMan |